UAB CFRC Administrative Core
UAB CFRC Administrative Core
批准号:
10673354
负责人:
David M. Bedwell
金额:
$13.96万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
未结题
起止时间:
2007-04-01 至 2028-04-30
关键词:
AccelerationAdvisory CommitteesAreaBiochemistryBiomedical ResearchBreast Fibrocystic DiseaseBusinessesCOVID-19Career MobilityCellsClinical SciencesCollaborationsCommunicationCommunitiesCore FacilityCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorDevelopmentDiabetes MellitusDiseaseEnsureEnvironmentEquipmentEvaluationEvolutionFacultyFosteringFoundationsFundingGoalsGrantGrowthHuman ResourcesInstitutionInterdisciplinary StudyInvestmentsLeadershipMedicineMolecular GeneticsMonitorMusNational Institute of Diabetes and Digestive and Kidney DiseasesNewsletterObesityParticipantPediatricsPositioning AttributeProceduresProductivityProgram DevelopmentRattusRecommendationResearchResearch PersonnelResourcesScienceScientistSiteSite VisitSystemTechnologyTrainingTranslational ResearchTranslationsUnited States National Institutes of HealthUtilization ReviewWritingbasecareer developmentclinical centerdrug developmentequipment acquisitionexperiencegene therapygenetic technologyinnovationinnovative technologiesinventionmeetingsmembermucus clearancenext generationnovelnutritionoperationpandemic diseaseprogramsresearch and developmentskillssuccesssymposiumsynergismweb site
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
The UAB Cystic Fibrosis Research and Translation Core Center Administrative Core is responsible for the
overall administration and coordination of the Biomedical Research Cores, Pilot & Feasibility Program, and
Enrichment Program. The Administrative Core is directed by Drs. Bedwell (P30 Director) Birket, and Solomon
(Associate Directors), along with continued involvement from Dr. Rowe (Associate Director) that additionally
serves to assure a seamless partnership with initiatives from the CF Foundation. Dr. Guimbellot will serve as
Co-Director of the Enrichment Program with Dr. Birket. Under this leadership, with assistance from the
experienced Research Management and Administrative Team (including Mr. Jeffrey Allison, Center
Administrative Director, and Dr. Emily Falk-Libby, Program Director-Scientific Affairs), the Core will continue to
successfully support CF Center goals in the upcoming funding cycle by: 1) Establishing the overall scientific
direction of the UAB P30 CF Center and ensuring continued contributions and growth into the most relevant
disease areas, including application of genetic therapies (e.g., directing communications between the
Administrative Core, P30 investigators, members of the Center’s active Internal Advisory Board, and/or
external consultants on its External Advisory Board to review Center activities and identify research directions
and opportunities), 2) Facilitating the objectives of all P30 components (e.g., prioritizing Core resources and
new equipment acquisition for optimal utilization, overseeing new state-of-the-art Core research space and
facilities, coordinating training and professional development activities, maintaining a Center website,
overseeing membership, building the Biomedical Core research base and monitoring its productivity,
supporting internal and external collaborations, managing successful operations in COVID-19), and 3)
Integrating P30 components with other UAB NIH Centers (e.g., promoting and sharing its innovative resources
and communicating with other Center leadership such as the Center for Clinical and Translational Science
(UAB’s CTSA site), NIDDK-Diabetes Research and Training Center, NIDDK-Nutrition Obesity Research
Center, and NIDDK-Hepatorenal Fibrocystic Diseases Core Center) to identify continued opportunities for
multidisciplinary collaboration. In addition, specifically in support of the Center’s Enrichment and Pilot &
Feasibility Programs, the Administrative Core will continue to identify and integrate resources offered through
the Institution to maximize trainee success and transition to independence for junior faculty as well as to apply
its established, robust mechanisms for solicitation, review, and oversight of P30 pilot applications to foster new
and important contributions to CF science. Overall, it is the goal of the Administrative Core to optimally
promote synergy and progress within the CF P30 Center.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
New Nonsense Suppression Drugs to Treat MPS I
-
批准号:8842247
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2014
-
负责人:David M. Bedwell
-
依托单位:
Mechanism of Eukaryotic Translation Termination
-
批准号:7997463
-
项目类别:
-
资助金额:$4.38万
-
财政年份:2009
-
负责人:David M. Bedwell
-
依托单位:
Suppression of the Idua-W402X mutation in an MPS I-H mouse
-
批准号:7340377
-
项目类别:
-
资助金额:$31.72万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
Suppression of the Idua-W402X mutation in an MPS I-H mouse
-
批准号:8015606
-
项目类别:
-
资助金额:$31.08万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
UAB CF Research and Translation Core Center
-
批准号:10673353
-
项目类别:
-
资助金额:$111.38万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
Suppression of the Idua-W402X mutation in an MPS I-H mouse
-
批准号:7179609
-
项目类别:
-
资助金额:$31.72万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
Animal Models Core
-
批准号:8320678
-
项目类别:
-
资助金额:$32.52万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
Suppression of the Idua-W402X mutation in an MPS I-H mouse
-
批准号:7560341
-
项目类别:
-
资助金额:$31.72万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
UAB CF Research and Translation Core Center
-
批准号:10468801
-
项目类别:
-
资助金额:$111.37万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
Mouse Models Core
-
批准号:7288652
-
项目类别:
-
资助金额:$16.12万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
Animal Models Core
-
批准号:8451289
-
项目类别:
-
资助金额:$31.28万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
Core B - Animal and Preclinical Models Core
-
批准号:10246451
-
项目类别:
-
资助金额:$31.96万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
Animal Models Core
-
批准号:8851578
-
项目类别:
-
资助金额:$32.52万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
Core B - Animal and Preclinical Models Core
-
批准号:10468805
-
项目类别:
-
资助金额:$31.96万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
Suppression of the Idua-W402X mutation in an MPS I-H mouse
-
批准号:7761315
-
项目类别:
-
资助金额:$31.4万
-
财政年份:2007
-
负责人:David M. Bedwell
-
依托单位:
Mechanism of Eukaryotic Translation Termination
-
批准号:7067093
-
项目类别:
-
资助金额:$27.4万
-
财政年份:2003
-
负责人:David M. Bedwell
-
依托单位:
Mechanism of Eukaryotic Translation Termination
-
批准号:7371536
-
项目类别:
-
资助金额:$30.45万
-
财政年份:2003
-
负责人:David M. Bedwell
-
依托单位:
Mechanism of Eukaryotic Translation Termination
-
批准号:7534977
-
项目类别:
-
资助金额:$34.66万
-
财政年份:2003
-
负责人:David M. Bedwell
-
依托单位:
Mechanism of Eukaryotic Translation Termination
-
批准号:7995246
-
项目类别:
-
资助金额:$29.84万
-
财政年份:2003
-
负责人:David M. Bedwell
-
依托单位:
Mechanism of Eukaryotic Translation Termination
-
批准号:6897183
-
项目类别:
-
资助金额:$28.06万
-
财政年份:2003
-
负责人:David M. Bedwell
-
依托单位:
海外基金